Background: Interest in the use of wearables in medical care is increasing. Wearables can
be used to monitor different variables, such as vital signs and physical activity. A crucial …

Melatonin has the ability to intervene in the initiation, progression and metastasis of some
experimental cancers. A large variety of potential mechanisms have been advanced to …

This randomized, double-blinded, placebo-controlled trial tested the hypothesis that 20mg of
melatonin before and during the first cycle of adjuvant chemotherapy for breast cancer …

Cancer represents a large group of diseases accounting for nearly 10 million deaths each
year. Various treatment strategies, including surgical resection combined with …

Cancer patients experience a number of co-occurring side-and late-effects due to cancer
and its treatment including fatigue, sleep difficulties, depressive symptoms, and cognitive …

Breast cancer is a common cancer in which patients are highly susceptible to different sleep
disturbances. However, current evidence lacked consistency in methodologies in …

Background Male testicular dysfunction is a considerable complication of anti-cancer
therapies, including chemotherapy and radiotherapy, partly due to the increased oxidative …

Rhythms following a period of approximately 24 hours are called circadian (from Latin circa
diem, approximately one day) rhythms. These rhythms are observed in the activities of …

Patients with non-central nervous system (CNS) cancer frequently report cognitive
complaints, that are recurrent and affect their quality of life. In order to improve supportive …

Background: Melatonin is a biomarker of the central circadian clock and its chronobiotic
actions entraining circadian rhythms to the light-dark cycle are well known. Reduction in …